Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • W vs GSK✓SelectedUSD · GSKW vs GSK performance historyLatest closeAs of-3.73%11/17
Stock and ETF performance explorer

W vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-59.4%
GSK return
+43.9%
Excess return
-103.3%
Maximum drawdown
-91.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.7%-2.3%-1.4%-3.0%
7D-4.9%-3.0%-1.9%-4.0%
30D-0.3%+0.4%-0.6%-0.3%
3M+3.8%-1.2%+5.0%+4.2%
6M+83.8%+0.9%+82.9%+83.1%
YTD+6.6%+4.0%+2.6%+4.3%
1Y+7.5%+7.3%+0.2%+4.1%
3Y+126.9%+57.1%+69.8%+83.8%
5Y-59.4%+43.0%-102.3%-67.5%
All-59.4%+43.9%-103.3%-67.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling